Steris (BSP:S1TE34) Inventories, Work In Process: R$474 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:S1TE34 Steris PLC BSP:S1TE34
23 GF Score
Price R$52.14
GF Value R$60.72
! 1 Warning Sign
View Full Analysis

What is Steris Inventories, Work In Process?

Steris BSP:S1TE34 23 Inventories, Work In Process is R$474 Mil as of Mar. 2026. GuruFocus rates BSP:S1TE34 with a GF Score™ of 23/100 and a GF Value™ of R$60.72. The stock has 1 warning sign investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Steris's work in process for the quarter that ended in Mar. 2026 was R$474 Mil.

Steris Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Steris's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Steris Inventories, Work In Process Chart

Steris Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 378.31 489.46 489.53 478.50 474.33

Steris Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 478.50 496.35 480.53 506.84 474.33
BSP:S1TE34
23GF Score
Steris PLC BSP:S1TE34
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Steris Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of R$474 Mil mean?
Steris (BSP:S1TE34) has a Inventories, Work In Process of R$474 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Steris and its competitors.
Is Steris' Inventories, Work In Process too high?
Steris' current Inventories, Work In Process is R$474 Mil. Overall, Steris has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Steris' Inventories, Work In Process compare to ZBH and GEHC?
Steris' Inventories, Work In Process of R$474 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Medical Devices & Instruments company?
A good Inventories, Work In Process depends on the Medical Devices & Instruments industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Steris and its competitors. Steris's current Inventories, Work In Process is R$474 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Steris stock overvalued right now?
Steris (BSP:S1TE34) has a current Inventories, Work In Process of R$474 Mil. The stock's GF Value™ is R$60.72, compared to a current price of R$52.14 — trading 14.1% below its estimated fair value. The current Inventories, Work In Process is R$474 Mil. Steris' overall GF Score™ is 23/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Steris (BSP:S1TE34), the current Inventories, Work In Process is R$474 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Steris (BSP:S1TE34) Overvalued in 2026?

Based on GuruFocus' analysis, Steris stock appears to be undervalued. The current stock price of R$52.14 is trading 14.1% below its estimated GF Value™ of R$60.72.

Key valuation signals for BSP:S1TE34:

  • Inventories, Work In Process: R$474 Mil
  • GF Value™: R$60.72 vs. price of R$52.14 (14.1% below fair value)
  • GF Score™: 23/100 with 1 warning sign

No single metric tells the full story. See the BSP:S1TE34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Steris Business Description

Other Exchanges STE:USA2TG:Germany
Address 70 Sir John Rogerson\'s Quay, Dublin, IRL, D02 R296
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
23GF Score

Get the complete analysis for BSP:S1TE34

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$52.14
Price
R$60.72
GF Value